ATE295725T1 - Valproinsäure und deren derivate als histondeacetylaseinhibitoren - Google Patents
Valproinsäure und deren derivate als histondeacetylaseinhibitorenInfo
- Publication number
- ATE295725T1 ATE295725T1 AT01962831T AT01962831T ATE295725T1 AT E295725 T1 ATE295725 T1 AT E295725T1 AT 01962831 T AT01962831 T AT 01962831T AT 01962831 T AT01962831 T AT 01962831T AT E295725 T1 ATE295725 T1 AT E295725T1
- Authority
- AT
- Austria
- Prior art keywords
- valproic acid
- derivatives
- histone
- histone deacetylase
- deacetylase inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00114088A EP1170008A1 (de) | 2000-07-07 | 2000-07-07 | Valproinsäure und dessen Derivate als Inhibitoren der Histone deacetylase |
PCT/EP2001/007704 WO2002007722A2 (en) | 2000-07-07 | 2001-07-05 | Valproic acid and derivatives thereof as histone deacetylase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE295725T1 true ATE295725T1 (de) | 2005-06-15 |
Family
ID=8169134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01962831T ATE295725T1 (de) | 2000-07-07 | 2001-07-05 | Valproinsäure und deren derivate als histondeacetylaseinhibitoren |
Country Status (10)
Country | Link |
---|---|
US (2) | US7265154B2 (de) |
EP (2) | EP1170008A1 (de) |
JP (1) | JP2004504347A (de) |
AT (1) | ATE295725T1 (de) |
AU (2) | AU2001283925B2 (de) |
CA (1) | CA2414967C (de) |
DE (1) | DE60110912T2 (de) |
ES (1) | ES2239677T3 (de) |
PT (1) | PT1301184E (de) |
WO (1) | WO2002007722A2 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1170008A1 (de) | 2000-07-07 | 2002-01-09 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Valproinsäure und dessen Derivate als Inhibitoren der Histone deacetylase |
GB0024362D0 (en) * | 2000-10-05 | 2000-11-22 | Glaxo Group Ltd | Medicaments |
WO2003018767A2 (en) * | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
EP1293205A1 (de) * | 2001-09-18 | 2003-03-19 | G2M Cancer Drugs AG | Valproinsäure und deren Derivate zur Kombinationsbehandlung von Krebs beim Menschen und zur Behandlung von Tumor-Metastasen und minimaler Resterkrankung |
US6706686B2 (en) | 2001-09-27 | 2004-03-16 | The Regents Of The University Of Colorado | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
WO2003032921A2 (en) | 2001-10-16 | 2003-04-24 | Sloan-Kettering Institute For Cancer Research | Treatment of neurodegenerative diseases and cancer of the brain |
CA2478479A1 (en) | 2002-03-07 | 2003-09-18 | University Of Delaware | Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phagebeta protein, or hydroxyurea |
IL149404A0 (en) * | 2002-04-29 | 2002-11-10 | Yissum Res Dev Co | METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION |
GB0226855D0 (en) | 2002-11-18 | 2002-12-24 | Queen Mary & Westfield College | Histone deacetylase inhibitors |
US20060247192A1 (en) * | 2002-12-05 | 2006-11-02 | Jenkinson John D | Control of apoptosis |
US7244751B2 (en) | 2003-02-14 | 2007-07-17 | Shenzhen Chipscreen Biosciences Ltd. | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
CA2518318A1 (en) * | 2003-03-17 | 2004-09-30 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
EP1491188A1 (de) * | 2003-06-25 | 2004-12-29 | G2M Cancer Drugs AG | Topische Verwendung von Valproinsäure zur Behandlung von Hauterkrankungen |
WO2005065681A1 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer |
WO2005066151A2 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
PT1591109E (pt) * | 2004-04-30 | 2008-09-05 | Desitin Arzneimittel Gmbh | Formulação exibindo libertação bifásica compreendendo um inibidor da desacetilase de histona |
KR100659779B1 (ko) | 2004-09-04 | 2006-12-19 | 주식회사 바이넥스 | 히스톤 디아세틸라제 억제제를 함유하는 중간엽줄기세포의 골분화유도용 조성물 및 이를 이용한 골분화증가방법 |
WO2006066133A2 (en) * | 2004-12-16 | 2006-06-22 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7642253B2 (en) * | 2005-05-11 | 2010-01-05 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
AU2006270322A1 (en) * | 2005-07-14 | 2007-01-25 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
JP2009525955A (ja) * | 2006-01-13 | 2009-07-16 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
WO2008011603A2 (en) * | 2006-07-20 | 2008-01-24 | Wisconsin Alumni Research Foundation | Modulating notch1 signaling pathway for treating neuroendocrine tumors |
US20080085874A1 (en) * | 2006-08-28 | 2008-04-10 | The Regents Of The University Of California | Small molecule potentiator of hormonal therapy for breast cancer |
GB0620823D0 (en) | 2006-10-19 | 2006-11-29 | Univ London | Histone deacetylase inhibitors |
CA2671649A1 (en) * | 2006-12-06 | 2008-06-12 | Sapporo Medical University | Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors |
US20090023186A1 (en) * | 2007-07-22 | 2009-01-22 | Excellgene Sa | Use of valproic acid for enhancing production of recombinant proteins in mammalian cells |
WO2009079375A1 (en) * | 2007-12-14 | 2009-06-25 | Georgetown University | Histone deacetylase inhibitors |
US8623853B2 (en) | 2008-07-23 | 2014-01-07 | The Brigham And Women's Hospital, Inc. | Treatment of cancers characterized by chromosomal rearrangement of the NUT gene |
ES2473792T3 (es) | 2009-04-03 | 2014-07-07 | Naturewise Biotech & Medicals Corporation | Compuestos cin�micos y derivados de los mismos para la inhibición de la histona desacetilasa |
US7994357B2 (en) | 2009-04-03 | 2011-08-09 | Naturewise Biotech & Medicals Corporation | Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
EP2277387B1 (de) | 2009-07-22 | 2016-10-19 | NatureWise Biotech & Medicals Corporation | Neue verwendung von histon-deacetylaseinhibitoren in veränderlichem mrjp3-protein in gelée royale |
EP2475769B1 (de) * | 2009-09-07 | 2016-11-09 | Jawaharlal Nehru Centre for Advanced Scientific Research | Hemmung von histonacetyltransferasen durch ctk7a und verfahren dafür |
US8921533B2 (en) | 2011-07-25 | 2014-12-30 | Chromatin Technologies | Glycosylated valproic acid analogs and uses thereof |
EP3470536A1 (de) | 2013-10-01 | 2019-04-17 | The J. David Gladstone Institutes | Zusammensetzungen, systeme und verfahren zum wirkstoffscreening auf genexpressionsrauschen und verwendungen davon |
AU2015252844A1 (en) * | 2014-05-02 | 2016-11-03 | Kay NOEL | Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds |
CN105622712B (zh) * | 2014-10-27 | 2019-08-27 | 天津金耀集团有限公司 | 一种甾体3-酮-4-烯物合成工艺 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
EP3863648A1 (de) * | 2018-10-12 | 2021-08-18 | Life Technologies Corporation | Expansionssystem für hämatopoietische stamm- und vorläuferzellen |
CN111358777A (zh) * | 2020-02-24 | 2020-07-03 | 军事科学院军事医学研究院环境医学与作业医学研究所 | 一种提高外周血单个核细胞线粒体功能的方法和应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672746A (en) * | 1994-08-30 | 1997-09-30 | American Biogenetic Sciences, Inc. | Antiproliferative and neurotrophic molecules |
US6300373B1 (en) * | 1993-09-10 | 2001-10-09 | American Biogenetic Sciences, Inc. | Antiproliferative and neurotrophic molecules |
EP1736152A3 (de) * | 1993-10-29 | 2009-10-07 | The Trustees Of Boston University | Physiologisch stabile Butlersäurepräparate, und Butlersäuresalze und Derivate zur Behandlung von Wunden |
CA2231251A1 (en) * | 1995-09-20 | 1997-03-27 | Merck & Co., Inc. | Histone deacetylase as target for antiprotozoal agents |
US6777217B1 (en) * | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
WO1997047307A1 (en) * | 1996-06-14 | 1997-12-18 | The Uab Research Foundation | Use of histone deacetylase inhibitors to activate transgene expression |
EP0961614A4 (de) * | 1996-12-30 | 2002-07-24 | Univ Bar Ilan | Oxyalkylester die tricarboxylsaeuren enthalten und deren verwendung |
US6387673B1 (en) * | 1997-05-01 | 2002-05-14 | The Salk Institute For Biological Studies | Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds |
AU1395999A (en) * | 1997-11-10 | 1999-05-31 | Salk Institute For Biological Studies, The | Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases |
US6262116B1 (en) * | 1998-01-23 | 2001-07-17 | Sloan-Kettering Institute For Cancer Research | Transcription therapy for cancers |
EP1170008A1 (de) | 2000-07-07 | 2002-01-09 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Valproinsäure und dessen Derivate als Inhibitoren der Histone deacetylase |
-
2000
- 2000-07-07 EP EP00114088A patent/EP1170008A1/de not_active Withdrawn
-
2001
- 2001-07-05 AT AT01962831T patent/ATE295725T1/de active
- 2001-07-05 AU AU2001283925A patent/AU2001283925B2/en not_active Ceased
- 2001-07-05 PT PT01962831T patent/PT1301184E/pt unknown
- 2001-07-05 WO PCT/EP2001/007704 patent/WO2002007722A2/en active IP Right Grant
- 2001-07-05 US US10/332,353 patent/US7265154B2/en not_active Expired - Fee Related
- 2001-07-05 ES ES01962831T patent/ES2239677T3/es not_active Expired - Lifetime
- 2001-07-05 DE DE60110912T patent/DE60110912T2/de not_active Expired - Lifetime
- 2001-07-05 JP JP2002513458A patent/JP2004504347A/ja not_active Ceased
- 2001-07-05 EP EP01962831A patent/EP1301184B1/de not_active Expired - Lifetime
- 2001-07-05 AU AU8392501A patent/AU8392501A/xx active Pending
- 2001-07-05 CA CA002414967A patent/CA2414967C/en not_active Expired - Fee Related
-
2007
- 2007-01-17 US US11/653,855 patent/US20070232696A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2004504347A (ja) | 2004-02-12 |
US7265154B2 (en) | 2007-09-04 |
US20040087652A1 (en) | 2004-05-06 |
WO2002007722A3 (en) | 2002-07-18 |
DE60110912D1 (de) | 2005-06-23 |
EP1170008A1 (de) | 2002-01-09 |
EP1301184B1 (de) | 2005-05-18 |
US20070232696A1 (en) | 2007-10-04 |
EP1301184A2 (de) | 2003-04-16 |
ES2239677T3 (es) | 2005-10-01 |
CA2414967C (en) | 2009-08-25 |
DE60110912T2 (de) | 2005-10-20 |
AU8392501A (en) | 2002-02-05 |
PT1301184E (pt) | 2005-07-29 |
AU2001283925B2 (en) | 2005-07-14 |
CA2414967A1 (en) | 2002-01-31 |
WO2002007722A2 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE295725T1 (de) | Valproinsäure und deren derivate als histondeacetylaseinhibitoren | |
CY1109551T1 (el) | Πρωτεασωμικοι αναστολεις και μεθοδοι χρησιμοποιησης αυτων | |
ATE408601T1 (de) | Fredericamycin-derivate | |
EA200501570A1 (ru) | Новые гидроксаматы как лечебные средства | |
EA200401284A1 (ru) | Замещённые бензазолы и их применение в качестве ингибиторов киназы raf | |
DE60325379D1 (de) | Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen | |
DK1692097T3 (da) | Tricykliske hydroxamat- og benzamidderivater, sammensætninger og fremgangsmåder | |
EA200401365A1 (ru) | Способы лечения илеуса | |
CY1116314T1 (el) | Συνθεσεις που περιεχουν ορνιθινη και οξικο φαινυλεστερα ή βουτυρικο φαινυλεστερα για τη θεραπεια της ηπατικης εγκεφαλοπαθειας | |
WO2004064727A3 (en) | Method of cancer treatment using hdac inhibitors | |
EA200401471A1 (ru) | Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов | |
CY1110133T1 (el) | Θεραπευτικος παραγων υπερλιπαιμιας που περιλαμβανει πιταβαστατινες και εικοσαπενταενοϊκο οξυ | |
ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
NO20030724L (no) | Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser | |
NO20045056L (no) | Fremgangsmater for behandling av hepatitt | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
DE602004004665D1 (en) | Acetylenderivate als inhibitoren von histondeacetylase | |
EA200500803A1 (ru) | Антагонисты ccr1 для лечения воспалительных артритов, демиелинизационных воспалительных заболеваний | |
BRPI0409796A (pt) | uso de dipiridamol ou mopidamol para tratamento e prevenção de doenças tromboembolìticas e distúrbios provocados pela formação excessiva de trombina e/ou pela expressão elevada de receptores de trombina | |
WO2006094068A3 (en) | Hdac inhibitors that promote brm expression and brm related diagnostics | |
DE60317098D1 (de) | Carbostyril-derivate mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von gemütskrankheiten | |
CY1111899T1 (el) | Καινοφανη παραγωγα πυρρολης με δραστηριοτητα αναστολεα της απακετυλασης της ιστονης | |
BRPI0413439A (pt) | combinações compreendendo estaurosporinas | |
ATE516038T1 (de) | Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen | |
ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1301184 Country of ref document: EP |